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1. Introduction 
Sexually transmitted infections (STIs) or sexually transmitted diseases (STDs) are common in 
low- income countries. Among adult women STIs (excluding HIV) represent around 9% of the 
disease burden (World Bank, 1993). This group of disease (Table 1) can lead to infertility, 
abortion, neonatal blindness and sometimes death. Furthermore in up to 75% of women STIs 
are thought to be asymptomatic, knowing also that vaginal discharge might be caused by non- 
sexually transmitted changes in vaginal flora (Sloan et al., 2000; Lush et al., 2003).   
 
Common STI syndrome Possible cause 
Genital ulcer disease 
Chancroid, Syphilis, Chlamydia, Herpes 
simplex virus, Donovanosis 
Urethral discharge Gonorhoea, Chlamydia 
Vaginal discharge 
Gonorhoea, Chlamydia, Herpes, 
trichomonas, Candida, Bacterial vaginosis 
Pelvic inflammatory disease Gonorhoea, Chlamydia 
Ophtalmia neonatorum Gonorhoea, Chlamydia 
Table 1. Common STI syndromes and possible causes Modified from Lush L, Walt G, Ogden 
J. (2003) Transferring policies for treating sexually transmitted infections: what’s wrong with 
global guidelines? Health Policy and planning 18(1): 18-30. 
Ophtalmia neonatorum (neonatal conjunctivitis) is an ocular redness, swelling and drainage 
(sometimes even purulent) due to a pathogenic organism or even chemical irritant occurring in 
infants less than 4 weeks of age with potentially serious ocular and systemic consequences 
(Merck Manual 2006, Rudolph’s 2002). The frequency of this disease varies up to 19% and is 
related to prenatal care (Rudolph’s 2002). 
Bacterial infection is acquired from infected mother during delivery. The most common 
bacteria is Chlamydia trachomatis causing Chlamydial ophtalmia occurring in 2 to 4% of 
births. This entity accounts for about one third to half of all conjunctivitis in neonates, 
characterizing developed countries (Current, 2009), while the prevalence of maternal 
chlamidial infection ranges from 2 to 20% (Mohile et al., 2002) with the incidence increasing 
dramatically through years (Miller, 2006). 
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Streptococcus pneumoniae and Haemophilus influenze as other bacteria responsible 
account for another 15% of cases. On the other hand, the incidence of conjunctivitis due to 
Neisseria gonorrhoeae (gonorrheal ophtalmia) in the USA is 2 to 3 per 10,000 births. 
Usually the isolation of other bacteria than mentioned above (e.g. Staphylococcus aureus) 
represents colonization.  
Herpetic kerato- conjunctivitis caused by herpes simplex virus types 1 and 2 represents the 
major viral infection, while chemical conjunctivitis is generally secondary to the instillation 
of ocular drops (e.g. silver nitrate) for prophylaxis purpose.  
2. Etiology 
Ophtalmia neonatorum may be caused by microorganisms (infectious etiology), or may be 
sterile (non infectious etiology) from chemical irritants (Table 2). Sterile or non infection 
ophtalmia neonatorum usually is caused by silver nitrate during prophylaxis of this entity. 
As far as infectious etiology concerns there are different bacteria and viruses known to cause 
this disease. The most commonly isolated bacteria are: Chlamydia trachomatis and Neisseria 
gonorrhoeae; but also: Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus 
viridians, Staphylococcus epidermidis, Escherichia coli, Klebsiella pneumoniae, Serratia 
marcescens, Proteus, Enterobacter, and Pseudomonas species. Also, Eikenella corrodens has 
been reported as a cause of neonatal conjunctivitis (Chhabra et al., 2008). The most 
commonly viral cause is Herpes simplex virus (HSV) associated most often with a 
generalized herpes simplex infection.  
 
Etiology Percentage (%) Incubation period Associated problems 
Chemical Varies 1 --- 
Chlamydia 
trachomatis 
2-40 5-14 Pneumonia 
Neisseria 
gonorrhoeae 
<1 2-7 
Disseminated 
infection 
HSV <1 6-14 
Disseminated 
infection 
Table 2. Pathogens of neonatal conjunctivitis  
Modified from "Red Book-Report of the Committee on Infectious Diseases, 29th Edition. The 
American Academy of Pediatrics.".http://aapredbook.aappublications.org/. 
2.1 Silver nitrate solution 
Silver nitrate solution is one the most common sterile causes of ophtalmia neonatorum. It 
was used for prophylaxis of ocular gonococcal infections as the most effective agent in 
prevention of ophtalmia neonatorum by direct inactivating of Gonococi. Crede's method 
was a major advance in preventing of ophtalmia neonatorum using 2% drops of Silver 
nitrate (Jatla et al., 2009). Later silver nitrate was found to be toxic for conjunctiva, causing 
chemical neonatal conjunctivitis, usually lasting 2-4 days. Because of replacement of silver 
nitrate with neomycin and chloramphenicol eye drops, and erythromycin ointment the 
incidence of chemical neonatal ophtalmia in the most countries have significantly decreased. 
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2.2 Chlamydia trachomatis 
It was postulated that unknown agent acquired from the genital tract of mother, is a cause of 
abacterial ophthalmia neonatorum (Kroner, 1884). Lindner comes to conclusion that 
inclusion of blennorrhoea was due to the trachoma agent, and after techniques evolution in 
Ophtalmology the first isolation was performed by Tang et al. This was realized by using 
the yolk sac of embryonated eggs and latter followed by isolating chlamydia from the 
babyes eyes with inclusion of blennorrhoea, and also from cervix of mother (Linder, 1909; 
T'ang et al., 1957; Jones et al., 1959).  
Chlamydia trachomatis is an intracellular parasite, one of the common causes of 
ophtalmia neonatorum 2-4% of births.  Chlamydia trachomatis, based on immunogenic 
epitope analysis of the major outer membrane protein (MOMP), differentiates in 18 
serovars. D to K serovars are common urogenital and ocular pathogens. Genotype 
classification correlates with the serovar classification previously mentioned (Rodriguez 
et al., 1993). Even though this classification is practical and accepted among researchers, it 
is found increased frequency of C. trachomatis genotype E in neonatal conjunctivitis 
(Lucía et al., 2010).  
It is thought that infants may acquire infection from their immediate surroundings, not only 
from mother birth canals. The high incidence of caesarean sections with high incidence of 
early onset conjunctivitis suggests in a possibility of intrauterine Chlamydial infection due 
to rupture of membrane. These kind of infections with Chlamydia trachomatis  are sexually 
transmitted and WHO estimated  90 million new cases in 1999 (World Health Organisation, 
2010). The developing risk of the Chlamydial infection as a conjunctivitis or pneumonia at 
birth is increased with an incidence up to 15% (Schachter et al., 1986; Numazaki et al., 2003; 
Rosenman et al., 2003).  
In some newborns with Chlamydia conjunctivitis, the infection persists too long with panus 
and scarring formation and after this, if this infection is left untreated it may be complicated 
even with pneumonia. Prevalence of this conjunctivitis is 8%.  (Hobson, 1977; Valencia et al., 
2000; Olatunji, 2004).  
Chlamydial conjunctivitis occurs after three days of life but may occur up to two weeks of 
life with mucopurulent and less inflamed discharge. Chlamydial conjunctivitis is associated 
with low risk of blindness compare to Gonorrheal conjunctivitis. 
2.3 Neisseria gonorrhoeae 
Neisseria gonorrhoeae was identified by Albert Neisser in 1879 in stained smears of 
exudates. Availability of Sulfonamides and Penicillin in 1943 was effective in treating of  
Gonorroheae (Kampmeier, 1978; Morton, 1977).  
In the past N. Gonorroheae was a common cause of conjuctivitis, but after 1881 based on 
observations of Crede (using the silver nitrate) the prevalence as a causative agent of 
ophtalmia is decreased, in the industrial zones from 10 to 0.3% (Di Bartolomeo et al., 
2001).  
Neisseria species are aerobic, gram negative, non motile and non spore forming. Gonococci 
occurs in pairs as diplococcal and have outer membrane overlying, a thin peptidoglycan and 
cytoplasmic membrane. The species lacks a true polysaccharide capsule but produces a 
surface polyphosphate that provides a hydrophilic, negatively charged surface. The 
microbes frequently are seen within phagocytes in Gram stains of clinical specimens 
(Noegel et al., 1983).  
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Gonococci have ability to adhere to mucosal epithelial cells and thus can survive, activating  
nuclear factor kappa B and activator protein 1, with release of numerous of cytokines and 
chemokines (Nauman et al., 1997; Ramsey et al., 1995). 
The individual gonococci can invade, replicate intracellulary, and by exocytosis can exit into 
the submucosal space (Alexey et al., 2000; Nauman et al., 1999). This lead in a chemotactic 
influx of neutrophils resulting in formation of micorabscesses and exudation of purulent 
material into lumen of infected tissues. Infection can persist for weeks to months if 
untreated because of escape immune response (Gergg et al., 1983; Casey et al., 1986; Shafer 
et al., 1986; Kallstrom et al., 1997).   
Incubation period of Neisseria gonorrhoeae in eye infection is 2 to 5 days and in some 
cases may arise 2 to 3 weeks (Gutman, 2001). Gonococcal conjunctivitis begins as benign 
and bilateral with eyelid edema, followed by chemosis. The discharge in the beginning is 
sero-sanguineous, later becomes thick and purulent, and may contain also blood. The 
infection can spread if treatment is delayed causing complications such as corneal 
ulceration and perforation, iridocyclitis, and panophtalmitis. From conjunctiva 
gonococcus can spread to cause gonococcus septicemia, arthritis, and other manifestations 
(Friendly, 1969).  
Staphylococcus aureus can cause ophtalmia neonatorum with purulent discharge. The 
treatment consists in topical or systemic antibiotic. In some cases spontaneous resolution can 
occur. Also, in Ophtalmia neonatorum are verified methicillin and erythromycin resistant S. 
aureus, but serious ophtalmologic infection was not found. In case of erythromycin-resistant 
Staphylococcus aureus conjunctivitis is used erythromycin ointment to prevent ophtalmia 
neonatorum (Cimolai, 2006; Hedberg et al., 1990).  
The group B Streptococcus also may causes ophtalmia neonatorum, and is resolved after 7 
days of treatment (Pöschl et al., 2002). 
Eikenella corrodens is a gram-negative bacillus, fastidious, slow growing, and facultative 
anaerobic bacterium. It is found as the normal flora of the human mouth, nasopharynx, 
gut, and genitourinary tract. In the last two decades has been recognized as cause of head 
and neck infections. It is presented as a cause of neonatal conjunctivitis (Chhabra et al., 
2008). 
Neonatal conjunctivitis also is caused from other bacteria such as: Staphylococcus 
epidermidis, Streptococcus pneumoniae, Haemophilus species, Klebsiella pneumoniae, 
Pseudomonas aeruginosa, and Escherichia coli (Martinez et al., 1993; Olatunji et al., 2007).  
2.4 Herpes simplex virus 
Herpes simplex virus (HSV) can lead to neonatal keratoconjuctivitis passing to the baby 
during childbirth. Although it is rare it might be associated with a generalized herpes 
simplex infection (Overall, 1994).  
2.5 Risk factors of neonatal conjuctivitis 
Risk factors of neonatal conjunctivitis may include: 
 Maternal infections 
 Exposure of the infant to infectious organisms 
 Increased birth weight 
 Inadequacy of ocular prophylaxis immediately after birth (Gichuhi et al., 2009) 
 Premature Rupture Of Membranes (Wu  et al., 2009)  
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 Ocular trauma during delivery 
 Mechanical ventilation 
 Prematurity 
 Poor prenatal care 
 Poor hygienic delivery conditions 
 Post-delivery infection due to direct contact with health care workers or by 
environment  
 Silver nitrate exposure 
3. Clinical findings 
The Clinical presentation of Neonatal Conjuctivitis varies depending upon the severity and 
the type of infection. The signs and symptoms of ophthalmia neonatorum are similar for 
most of the infectious agents (Foster, 1995). Diffuse unilateral or bilateral redness due to 
injection of conjuctival vessels is the hallmark. Other common findings incude conjuctival 
oedema and discharge. More serious finding include keratitis and orbital celulitis, but also 
serious systemic involvement if left untreated (Woods, 2005; Zar, 2005). It is necessary to 
make accurate diagnosis in order to begin appropriate treatment which can help to reduce 
complications (Table 3). 
3.1 Chemical conjunctivitis 
It is present with mild injection of conjunctiva with minimal discharge. It is important that 
these occur within few hours after application of irritant. Sometimes the persistent redness 
of the eye might be folowed by purulent discharge and in that case there is a need for 
further laboratory investigation.   
3.2 Bacterial conjunctivitis 
The occurrence time and severity of clinical features depend on the type of microorganism.  
Gonococal conjunctivitis 
During this infection there is a severe redness, swelling of conjunctiva and eyeleads, and a 
lot of purulent drainage presenting few days after birth (Woods 2005), but may occur later 
as hyperacute conjunctival injection and chemosis, lid oedema and severe purulent 
discharge. Corneal ulceration and perforation may be associated features (Jackson, 2008).  
Hyperacute conjunctivitis has the incubation period 1-7 days (Isenberg et al., 1996; Chandler 
et al., 1990), often bilateral and signs are more severe. Serosanguinous exudate may be 
replaced by mucopurulent discharge, with development of membranes. A disseminated 
gonococcal infection with arthritis, meningitis, pneumonia and sepsis that may lead to death 
of an infant is very rare. 
Chlamydial conjunctivitis 
Cervical infection with Chlamydia carries a risk to the neonate of 18-50% (Vaz et al., 1999; 
Schachter et al., 1986; Hollier et al., 2009; Roberts, 2009). The clinical features present at 5 to 
14 days after birth with gradually worsening. Eyelids and conjunctiva are  redness and 
swollen (Figure 1), and mucopurrulent drainage is present. It may also occur severe 
swelling and discharge with a course of 6 to 12 weeks (if left untreated) leading to scars of 
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conjunctiva and cornea. In this case, if untreated or even only topically treated, may worsen 
with upper respiratory infection, in severe cases with afebrile pneumonitis usually 
presenting at 2 to 20 months of age (Darville, 2005). Approximately 50% of infants with 
chlamydial pneumonitis have concurrent conjunctivitis or a recent history of conjunctivitis 
(Tarabishy et al., 2008). 
 
 
Fig. 1. Neonatal conjuctivitis due to chlamydia trachomatis in a five days old infant  
Staphylococcus conjunctivitis. Staphylococcus aureus can cause neonatal conjuctivitis with 
redness, swollen purulent discharge (Figure 2).  
 
 
Fig. 2. Neonatal conjuctivitis due to staphylococcus aureus infection in an one week old 
infant.  
3.3 Herpetic conjunctivitis 
It is present usually the first two weeks of life with moderate injection, edema of conjuctiva 
and nonpurrulent discharge after vesicular skin lesions which can precede the eye 
involvment. In some cases it may be complicated with corneal clouding with dentritic or 
geographic corneal ulcers or upper respiratory infection (Rudolph, 2002). Systemic infection 
can cause jaundice, hepatosplenomegaly, pneumonitis, meningoencephalitis and 
disseminated intravascular coagulation. 
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Etiology Onset after birth Clinical findings 
Chemical 3-36 hours 
Mild injection, watery 
dicharge 
Gonnococal 1-7 days 
Injection and lead edema, 
purulent discharge 
Chlamydial 5-14 days 
Mild- severe injection, watery- 
purulent discharge, 
psudomembranes, chronicity, 
associated pneumonia 
Herpetic 1-14 days 
Watery discharge, injection 
and lead edema, associated 
keratitis 
Table 3. Clinical findings of neonatal conjunctivitis by etiological factor modified from 
Rudolph’s fundametntals of Pediatrics, 2002 
4. Diagnosis 
Prompt diagnosis is key in establishing proper treatment and minimizing potential serious 
complications of disease. An accurate diagnosis of conjunctivitis centers on taking a patient 
history to learn when symptoms began, how long the condition has been going on, the 
symptoms experienced, and other predisposing factors, such as upper respiratory 
complaints, allergies, sexually transmitted diseases, herpes simplex infections, and exposure 
to persons with pink eye. It may be helpful to learn whether an aspect of an individual's 
occupation may be the cause.  
A thorough examination of the globe and periocular structures of a neonate suspected to 
have neonatal conjunctivitis is crucial. Corneal involvement should be investigated closely 
with and without fluorescein and blue cobalt light. Non-specific signs of neonatal 
conjunctivitis include conjunctival injection, tearing, mucopurulent or non-purulent 
discharge, chemosis, and eyelid swelling. 
Diagnostic tests are usually not indicated unless initial treatment fails or an infection with 
gonorrhea or chlamydia is suspected. In such cases, the discharge may be cultured and 
stained to determine the organism responsible for causing the condition. Cultures and 
smears are relatively painless (Jackson, 2008). 
Laboratory studies for suspected infectious etiology should include the following (Table 4 
and 5): 
 Conjunctival scraping, stains for Chlamydia. C. trachomatis is an obligate intracellular 
organism and exudates are not adequate for testing so conjunctival specimens for 
chlamydia testing must include conjunctival epithelial cells;  
 Culture on chocolate agar for N gonorrhoeae ;  
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 Culture on blood agar for other strains of bacteria;  
 Culture for HSV if vesicles present or is supicious of viral etiology; 
 Direct antibody testing or Polymerase Chain Reaction (PCR) may also be indicated. 
The laboratory studies may need to be repeated if symptoms worsen or recur following 
treatment. 
 
 
Etiology Laboratory diagnosis 
Chemical - 
Gonnococal Stain and cultures 
Chlamydial 
Stain, cultures, enzyme immunoassay, direct fluorescent 
antibody assay 
Herpetic Stain, cultures, antigen or DNA assay 
 
Table 4. Laboratory diagnosis based on etiology 
Modified from Rudolph’s fundametntals of Pediatrics, 2002 
 
 
Etiology Conjuctival Scraping 
Chemical 
Minimal reactive cells to few 
polymorphonuclears 
Gonococcal 
Many reactive cells with gram 
negative intracellular dyplococci 
Chlamydial 
Many reactive cells with stain for 
basophilic cytoplasmic inclusion 
bodies or direct immunofluorescent 
assay 
Other bacteria (Staphylococcus, 
Streptococcus, Haemophilus) 
Stain for bacteria 
Herpes simplex virus 
Variable reactive cells with 
multinucleated giant cells 
 
Table 5. Conjuctival scraping findings in ophtalmia neonatorum 
Modified from Duane's Clinical Ophthalmology, 2008 
5. Differential diagnosis 
The differential diagnosis of neonatal conjunctivitis includes:  
 Cellulitis (Orbital, Preseptal) 
 Dacryocystitis 
 Glaucoma, Primary or Secondary Congenital 
 Keratitis, Bacterial, Fungal or Herpes Simplex 
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6. Complications 
Complications usually can be divided concerning eye and/or systemic complications. 
Ocular complications of neonatal conjunctivitis include pseudomembrane formation, 
corneal edema, thickened palpebral conjunctivia, peripheral pannus formation, corneal 
opacification, staphyloma, corneal perforation, endophthalmitis, loss of eye, and blindness.  
Systemic complication due to Chlamydia infection 
Systemic complications of chlamydia conjunctivitis include pneumonitis, otitis, pharyngeal 
and rectal colonization. Pneumonia has been reported in 10-20% of infants with chlamydial 
conjunctivitis. 
Systemic complications due to gonococcal infection 
Complications of gonococcal conjunctivitis and subsquent systemic involvement include 
arthritis, meningitis, anorectal infection, septicemia, and death. 
The complications can be avoided if the proper treatment is initiated at time. 
7. Treatment 
7.1 Initial therapy 
Ophtalmia neonatorum is treated with a broad-spectrum antibiotic e.g. ofloxacin 0.3% qds. 
When the microbiological results is present the treatment is based on microbiological cause 
(Jackason, 2008).  
7.2 Chemical ophtalmia neonatorum 
Chemical neonatal conjunctivitis usually disappears spontaneously within 2-4 days, and no 
treatment is required. The use of artificial tear is preferred. 
7.3 Chlamydial ophtalmia neonatorum 
The recommended regimen for chlamydial neonatal conjunctivitis is erythromycin base or 
ethylsuccinate, as a systemic therapy, 50mg per kg per day orally, divided into four doses 
per day for two weeks (Table 6). A follow-up of infants is recommended to determine 
whether initial treatment was effective because the efficacy is only approximately 80% and a 
second course of therapy might be required. Also, the evaluation of concomitant chlamydial 
pneumonia should be considered (Sexually transmitted disease treatment guidelines, 2010; 
Lippincott Williams & Wilkins, 2008; Yanoff & Duker, 2008). 
The systemic treatment is administred as additional to topical treatment. (Sexually 
transmitted disease treatment guidelines, 2010). From local antibiotics usually are applied 
erythromycin 0.5% or tetracycline 1% eye ointment.  
The mother and her sexual partners also should be treated with erythromycin base or 
ethylsuccinate (Sexually transmitted disease treatment guidelines, 2010).  
7.4 Gonococcal ophtalmia neonatorum 
The immediate treatment is needed because of complications such as corneal perforation 
and blindness. Gonococcus conjunctivitis is treated with ceftriaxone 25-50mg/kg IV or IM in 
a single dose (Table 6), not to exceed 125mg. An alternative regimen is cefotaxime 
100mg/kg/24 hours IV or IM divided in two doses for seven days or 100mg/kg as a single 
dose. The irrigation with saline is preferred until the purulent discharge is cleared. The local 
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antibiotics such as bacitracin or erythromycin eye ointment are applied as additional 
therapy because topical antibiotic alone is inadequate. The atropine sulphate ointment 
should be applied if the cornea is involved (Sexually transmitted disease treatment 
guidelines, 2010; Lippincott Williams & Wilkins, 2008; Yanoff & Duker, 2008). 
The mothers of infants and mother’s sex partners should be evaluated and treated according 
to the recommendations for treating gonococcus infections in adults (Sexually transmitted 
disease treatment guidelines, 2010).  
Neonatal conjunctivitis due to other bacteria usually respond to topical ointments 
containing bacitracin for gram positive stain bacteria, and tobramycin or ciprofloxacin for 
gram negative stain bacteria. 
 
Type of bacteria Drug Dose for day Duration 
Chlamydia 
trachomatis 
Erythromycin 50mg/kg 14 days 
Nesseria gonorrhoeae Ceftriaxone 25-50mg/kg A single dose 
Table 6. Recommended regimens for bacterial neonatal conjuctivitis 
Modified from Sexually transmitted disease treatment guidelines 2010. Centers for Disease 
Control and Prevention, MMWR Recomm Rep 2010; 59 (RR-12): 53-54. 
7.5 Herpetic ophtalmia neonatorum 
Herpetic neonatal conjunctivitis is recommended to be treated with acyclovir 45-
60mg/kg/day in three doses for 14 days in non disseminated disease and 21 days in 
disseminated disease. Local antiviral therapy is 1% trifluridine or 3% vidarabine or 0.1% 
iododeoxyuridine (drops or ointment) (Lippincott Williams & Wilkins, 2008).  
8. Prophylaxis 
8.1 Silver nitrate prophylaxis 
German obstetrician Credé', in 1881, has applied 2% silver nitrate solution for prophylaxis of 
neonatal ophtalmia, resulting in a reduction of incidence from 7.8% to 0.17%. Thereafter was 
started instillation of silver nitrate, based on legislation, in most European countries and 
most of North America states in the first half of last century (Schneider, 1984; Crede CSR, 
1881; Barasam, 1966). Latest in 1970s approximately half the United States specified 1% 
silver nitrate solution as the sole agent (Hammerschlag MR et al., 1908). In the United 
Kingdom the procedure has been discontinued, and in Japan and Australia, it was never 
used (Shaw EB, 1977). The mother usually can be representative consent of using of Credé's 
method in Sweden (Wahlberg V, 1982). The decision for changing of the Wisconsin law in 
1980 that tetracycline and erythromycin could be used for prophylaxis against GON was 
based on a previous ruling by US Supreme Court (Whittaker N et al., 1981). 
The siver nitrate, which by law is instilled within 1 hour after birth, may cause chemical 
conjunctivitis pain and visual impairment. The silver nitrate does not prevent all cases of 
gonococcal neonatal conjunctivitis. The chemical conjunctivitis caused by silver nitrate may 
mask the onset of gonococcus neonatal conjunctivitis (Shaw, 1977; Snowe et al., 1973). 
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Since 1940s, when antibiotics were developed the incidence of gonococcal neonatal 
conjunctivitis was decreased dramatically (Butterfield et al., 1981).  
Recommendations of the US Centers for Disease Control (CDC) are supported from 
American Academy of Pediatrics in 1986 and 1988. According to these recommendations 1% 
tetracycline ointment and 0.5% erythromycin ointment were equally acceptable in 
preventing of gonococcus ophtalmia neonatorum. Although it was felt that silver nitrate 
might be the best agent in areas where the incidence of penicillinase-producing neisseria 
gonorrhoeae (PPNG) was appreciable (Peter, 1988). 
The CDC's 1989 guidelines on the treatment of sexually transmitted diseases were 
unchanged with respect to the prevention of ophthalmia neonatorum (Sexually Transmitted 
Diseases Treatment Guidelines, 1989).  
In Canada the incidence of PPNG among reported cases of gonorrhea increased from 0.5% 
in 1985 to 5.5% in 1989 (Status of penicillinase-producing Neisseria gonorrhoeae in 
Canada, 1991). 
In 1989 the US Preventive Services Task Force recommended that 1% tetracycline ointment or 
0.5% erythromycin ointment have to be applied topically to the eyes of all newborns as soon as 
possible after birth and no later than 1 hour after birth (Preventive Services task Forces, 1989). 
Silver nitrate was not recommended since it is locally irritating, frequently causing chemical 
conjunctivitis, and has limited efficacy in preventing chlamydial ophthalmia neonatorum. 
8.2 Povidon-iodine prophylaxis 
In 1995, is reported the use of a 2.5% povidone-iodine solution for prophylaxis of ophtalmia 
neonatorum in Kenya, and was found to be more effective than treatment with 
erythromycin or silver nitrate for prophylactic purposes. Also, the povidone-iodine was less 
toxic and it costs less (Isenberg et al., 1995).  
The povidone-iodine prophylaxis against ophtalmia neonatorum, applied twice in the first 
postnatal day over a single application at birth, revealed with no advantage. It was 
supported the original notion of Crede in 1881 that a single drop of an effective medication 
given at birth is the best way to prevent the development of ophtalmia neonatorum.  The 
povidone-iodine applications approximately 24 hours later were with no further benefit.  
8.3 Antibiotics prophylaxis  
The procedure for prevence of gonococcal ophthalmia neonatorum is required by law in 
most states. Prophylactic agent should be instilled into the eyes of newborns. But, the 
efficacy of prophylactic agents in preventing chlamydial ophthalmia is clearless, and they 
do not eliminate nasopharyngeal colonization by C. trachomatis.  
This preparation should be instilled into both eyes of every neonate as soon as possible after 
delivery. Ideally, ointment should be applied using single-use tubes or ampoules rather than 
multiple-use tubes. If prophylaxis is delayed (i.e., not administered in the delivery room), a 
monitoring system should be established to ensure that all infants receive prophylaxis. All 
infants should be administered ocular prophylaxis, regardless of whether they are delivered 
vaginally or by cesarean section. 
Antibiotics that are applied in prevention of gonococcal ophtalmia are tetracycline and 
erythromycin and are more effective than silver nitrate (Rothenberg, 1979; American Academy 
of Pediatrics, 1980). Erythromycin is less effective than tetracycline against sensitive isolates of 
N. gonorrhoeae in vitro. Canadian Paediatric Society in 2010 has revised recommandations for 
the prevention of neonatal ophthalmia due to N gonorrhoeae (Table 7).   
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Recommendation Category Grade 
Prophylaxis to prevent neonatal ophthalmia due to N gonorrhoeae 
should be provided to all infants. 
A 1 
Physicians and their patients may choose among the recommended 
prophylactic agents - that is, 1% silver nitrate solution in single-
dose ampoules, or an ointment containing 0.5% erythromycin base 
or 1% tetracycline hydrochloride in single-dose tubes. 
A 1 
The use of povidone-iodine for ophthalmia prophylaxis. C 1 
To prevent potential cross-contamination, a separate ampoule or 
tube should be used for each eye. Ampoules and tubes should be 
discarded after use. 
A 3 
When 1% silver nitrate solution is used, each eyelid should first be 
wiped gently with a sterile cotton ball to remove foreign matter and 
permit adequate eversion of the lower lid. Two drops of solution are 
placed in each lower conjunctival sac. The closed eyelids can be 
massaged gently to help spread the solution to all areas of the 
conjunctiva. After 1 min, any excess silver nitrate should be gently 
wiped from the eyelids and surrounding skin with sterile cotton. 
A 3 
When an ophthalmic ointment (tetracycline or erythromycin) is used, 
the eyelids should be prepared as for the application of silver nitrate. 
A line of ointment 1 to 2 cm long is placed in each lower conjunctival 
sac, if possible covering the whole lower conjunctival area. Care is 
needed to prevent injury to the eye or the eyelid from the tip of the 
tube. The closed eyelids can be massaged gently to help spread the 
ointment. After 1 min, any excess ointment should be wiped gently 
from the eyelids and surrounding skin with a sterile cotton. 
A 3 
The eyes should not be irrigated after instillation of a prophylactic 
agent. Irrigation may reduce the efficacy of the agent and probably 
does not decrease the incidence of chemical conjunctivitis caused 
by silver nitrate. 
A 3 
Prophylaxis should be given as soon as possible after birth. 
However, delaying prophylaxis for up to 1 h after birth probably 
does not impair the agent's efficacy. 
B 3 
A check system should be established to ensure that all infants are 
treated. 
A 3 
Infants born by caesarian section should also receive prophylaxis. B 3 
Pregnant women should be screened for infection by N 
gonorrheoae and C trachomatis during pregnancy and their 
identified infections should be treated during pregnancy. 
A 3 
Infants born to women with gonococcal infection discovered 
during labour or at the time of delivery should be given a single 
dose of ceftriaxone (25 to 50 mg/kg) or cefotaxime (100 mg/kg) in 
addition to topical prophylaxis. 
A 2 
 
Table 7. Recommandations for the prevention of neonatal ophthalmia due to N gonorrhoeae 
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Modified from Canadian Pediatric Society. Revised Recommandations for the prevention of 
neonatal ophtalmia, 2010. 
Classification used to determine the strength of the recommendations and the quality of the 
evidence on which the recommendations are based. 
 
Category Definition 
A Good evidence to support a recommendation for use 
B Moderate evidence to support a recommendation for use 
C Insufficient evidence to support a recommendation for or against use 
D Moderate evidence to support a recommendation against use 
E Good evidence to support a recommendation against use  
Grade 
1 Evidence from at least one properly randomized, controlled trial 
2 
Evidence from at least one well-designed clinical trial without 
randomization, from cohort or case- controlled analytic studies, preferably 
from more than one centre, from multiple time series, or from dramatic 
results in uncontrolled experiments 
3 
Evidence from opinions or respected authorities on the basis of clinical 
experience, descriptive studies or reports of expert committees 
Source. Canadian Pediatric Society. Revised Recommandations for the prevention of neonatal 
ophtalmia, 2010. 
Table 8. 
Tetracycline as silver nitrate does not prevent completely chlamydial ophtalmia neonatorum 
(Laga et al., 1988, Canadian Task Force on the Periodic Health Examination, 1992). There 
were no significant differences between the rates of chlamydial ophtalmia neonatorum 
when prophylaxis with erythromycin was compared with prophylaxis with tetracycline or 
silver nitrate. For a modest reduction in chlamydial ophtalmia neonatorum now are 
recommended the agents for gonococcal prophylaxis. 
Erythromycin 0.5 % is the only antibiotic ointment recommended for use in neonates in each 
eye in a single application. Silver nitrate and tetracycline ophthalmic ointment are no longer 
manufactured in the United States, bacitracin is not effective, while povidone iodine has not 
been studied adequately (Sexually Transmitted Diseases Treatment Guidelines, 2010). 
If erythromycin ointment is not available, infants at risk for exposure to N. gonorrhoeae 
(especially those born to a mother with untreated gonococcus infection or who has received 
no prenatal care) can be administered ceftriaxone 25-50 mg/kg IV or IM, not to exceed 125 
mg in a single dose (Sexually Transmitted Diseases Treatment Guidelines, 2010). 
The diagnosis and treatment of gonococcal and chlamydial infections in pregnant women 
is the best method for preventing neonatal gonococcal and chlamydial disease. Also 
preventative measures include proper hand-washing techniques by peripartum and 
nursery staff. 
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9. Prognosis 
 Chlamydial infection: good - 80% fully recover after one course of treatment.  
 Bacterial infection: rarely fails to respond to appropriate treatment.  
 Viral infection: the ocular prognosis can be poor and the systemic sequelae may be fatal. 
 Chemical irritation: good - full spontaneous recovery expected after 24-36 hours.  
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